[Therapy of chronic cholecystitis].
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002635:Chenodeoxycholic Acid / Q000627:therapeutic use; D002764:Cholecystitis / Q000188:drug therapy*; D002908:Chronic Disease; D006801:Humans; D009675:Novobiocin / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use*; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D010276:Parasympatholytics; D010406:Penicillins; D010455:Peptides; D002635:Chenodeoxycholic Acid; D009675:Novobiocin; D000667:Ampicillin; D012293:Rifampin
Terapia delle colecistiti croniche